The Food and Drug Administration (FDA) has approved updated safety label on numerous testosterone replacement therapies to include a new subsection under Warnings and Precautions regarding the risk of abuse. The warning also advises physicians to check serum testosterone concentration in men if testosterone abuse is suspected, to counsel patients of possible serious adverse reactions associated with abuse of testosterone and anabolic androgenic steroids (AAS), and to consider the possibility of testosterone and AAS abuse in suspected patients who present with serious cardiovascular or psychiatric adverse events. In October, the FDA announced it had ordered the safety label changes to ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.